# Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus

> **NCT02284269** · — · UNKNOWN · sponsor: **Pharmaceuticals and Medical Devices Agency, Japan** · enrollment: 18000 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** SGLT2 Inhibitors

## Key facts

- **NCT ID:** NCT02284269
- **Lead sponsor:** Pharmaceuticals and Medical Devices Agency, Japan
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2020-05
- **Final completion:** —
- **Target enrollment:** 18000 (ESTIMATED)
- **Last updated:** 2016-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02284269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02284269, "Meta-analysis in Post-marketing Surveillances for SGLT2 Inhibitors in Patients With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02284269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*